Cargando…

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It’s Not All Pharmacokinetics

Hemophilic arthropathy from joint bleeding remains a complication with major morbidity in the increasingly aging patients with hemophilia. Prophylactic clotting factor infusions, based on pharmacokinetic dosing to reduce bleeding rates, are being explored more and more. However, there is little evid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jenny Y., Barnes, Richard F. W., Foster, Gary, Iorio, Alfonso, Cramer, Thomas J., von Drygalski, Annette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714908/ https://www.ncbi.nlm.nih.gov/pubmed/31298044 http://dx.doi.org/10.1177/1076029619862052

Ejemplares similares

Investigation of the Bleeding Tendency in Sudanese Female Carriers of Hemophilia B
por: Abker, Ismail Ali Abdallah, et al.
Publicado: (2022)

The Hypertension of Hemophilia Is Not Explained by the Usual Cardiovascular Risk Factors: Results of a Cohort Study
por: Barnes, Richard F. W., et al.
Publicado: (2016)

Knee Fat Pad Volumes in Patients with Hemophilia and Their Relationship with Osteoarthritis
por: von Drygalski, Annette, et al.
Publicado: (2017)

Data Analysis Protocol for the Development and Evaluation of Population Pharmacokinetic Models for Incorporation Into the Web-Accessible Population Pharmacokinetic Service - Hemophilia (WAPPS-Hemo)
por: McEneny-King, Alanna, et al.
Publicado: (2016)

Evaluating Gene Therapy as a Potential Paradigm Shift in Treating Severe Hemophilia
por: Thornburg, Courtney D., et al.
Publicado: (2023)

Development of a Web-Accessible Population Pharmacokinetic Service—Hemophilia (WAPPS-Hemo): Study Protocol
por: Iorio, Alfonso, et al.
Publicado: (2016)

The role of point-of-Care Musculoskeletal Ultrasound for Routine Joint evaluation and management in the Hemophilia Clinic - A Real World Experience
por: Gallastegui, N, et al.
Publicado: (2022)

Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers
por: Gooding, Richard, et al.
Publicado: (2021)

Focusing in on use of pharmacokinetic profiles in routine hemophilia care
por: Croteau, Stacy E., et al.
Publicado: (2018)

Joint Dysfunction as a Cause of Spontaneous Subclinical Bleeding in Infants with Hemophilia
por: Boccalandro, Elena Anna, et al.
Publicado: (2023)

An Engineered Factor Va Prevents Bleeding Induced by Anticoagulant wt Activated Protein C
por: von Drygalski, Annette, et al.
Publicado: (2014)

Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
por: Teitel, Jerome, et al.
Publicado: (2021)

Pharmacokinetic‐tailored approach to hemophilia prophylaxis: Medical decision making and outcomes
por: Croteau, Stacy E., et al.
Publicado: (2020)

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review
por: Shapiro, Amy D., et al.
Publicado: (2022)

Bleeding phenotype in nonsevere hemophilia by International Society on Thrombosis and Haemostasis bleeding assessment tool, bleeding frequency, and the joint status
por: Rejtő, Judit, et al.
Publicado: (2023)

Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review
por: Yu, Jacky K., et al.
Publicado: (2019)

Consistency of serial ultrasonographic joint tissue measurements by the Joint (tissue)Activity and Damage Exam (JADE) protocol in relation to hemophilic joint health parameters
por: Barnes, Richard F. W., et al.
Publicado: (2023)

Bleeding management: rFVIIIFc in hemophilia A and liver transplantation
por: Grottke, Oliver, et al.
Publicado: (2023)

Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
por: Nguyen, S., et al.
Publicado: (2019)

Thrombomodulin in patients with mild to moderate bleeding tendency
por: Mehic, Dino, et al.
Publicado: (2021)

Quantitative measurements of haemophilic joint tissues by point‐of‐care musculoskeletal ultrasound: Associations with clinical and functional joint outcome parameters
por: Mesleh Shayeb, Akram, et al.
Publicado: (2021)

Acquired Hemophilia A with Gastrointestinal Bleeding
por: Park, Narae, et al.
Publicado: (2020)

The bleeding phenotype in people with nonsevere hemophilia
por: Kloosterman, Fabienne R., et al.
Publicado: (2022)

Pharmacokinetic variability of factor VIII concentrates in Chinese pediatric patients with moderate or severe hemophilia A
por: Chen, Zhenping, et al.
Publicado: (2021)

Diagnostic Values of Inflammatory and Angiogenic Factors for Acute Joint Bleeding in Patients With Severe Hemophilia A
por: Xu, Huijuan, et al.
Publicado: (2020)

Sertraline-Related Bleeding Tendency: Could It Be Dose-Dependent?
por: Eslami Shahrbabki, Mahin, et al.
Publicado: (2014)

Diagnostic work up of patients with increased bleeding tendency
por: Zegers, Suzanne A. M., et al.
Publicado: (2019)

Factor VIII activity and bleeding risk during prophylaxis for severe hemophilia A: a population pharmacokinetic model
por: Tiede, Andreas, et al.
Publicado: (2020)

Population Pharmacokinetic Analysis and Exploratory Exposure–Bleeding Rate Relationship of Emicizumab in Adult and Pediatric Persons with Hemophilia A
por: Retout, Sylvie, et al.
Publicado: (2020)

Prevention and Management of Bleeding Episodes in Children with Hemophilia
por: Ljung, Rolf C. R.
Publicado: (2018)

An Unusual Case of Bleeding: Acquired Hemophilia A
por: Jahangiri, Omeed S, et al.
Publicado: (2023)

An engineered activated factor V for the prevention and treatment of acute traumatic coagulopathy and bleeding in mice
por: Joseph, Bilgimol Chumappumkal, et al.
Publicado: (2022)

Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

PROTHROMBIN DEFICIENCY AND THE BLEEDING TENDENCY IN LIVER INJURY (CHLOROFORM INTOXICATION)
por: Smith, H. P., et al.
Publicado: (1937)

Fatigue, bleeding tendency and osteoporosis in an adolescent: a diagnostic conundrum
por: Ku Md. Saad, Salwana, et al.
Publicado: (2023)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
por: Sarmiento Doncel, Samuel, et al.
Publicado: (2021)

Real pandemic world results of pharmacokinetic-tailored personalized prophylaxis of bleeds in Polish children and adolescents with severe hemophilia A
por: Urasiński, Tomasz, et al.
Publicado: (2023)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
por: Chelle, Pierre, et al.
Publicado: (2021)

Review of antihemophilic factor injection for the routine prophylaxis of bleeding episodes and risk of joint damage in severe hemophilia A
por: Rossbach, Hans-Christoph
Publicado: (2010)

Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients
por: Chelle, Pierre, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hrinjsrbghdtcejguamgf6nij6